A law forming the legal foundation for a medical cannabis industry in Barbados has overcome the last important parliamentary hurdle after being approved by the Eastern Caribbean country’s Senate.
The law, which covers activities related to cultivation, processing, dispensing and export, empowers the Medicinal Cannabis Licensing Authority to develop policies and guidelines for a newly regulated medicinal marijuana industry.
The Senate passed the Medicinal Cannabis Industry Bill at close to midnight on Nov. 27, two weeks after it won approval in the House of Assembly.
The governor general signed off on both pieces of legislation, and they were published in the Extraordinary Gazette on Nov. 29, making them official.
The island will adopt a tiered approach to cultivation and processor permits, ranging from Tier 1 for small-scale cultivation to Tier 3 for large-scale farms.
Barbados will require license holders to be citizens, permanent residents, hold immigrant status (which can be gained through investing) or be a citizen of a Caribbean Community (CARICOM) member state.
The Cannabis Industry Bill allows medical cannabis to be prescribed by a practitioner to Barbadians or visitors to the island.
The bill moved through the parliamentary process quickly after being first introduced in August.
Sen. Crystal Haynes clarified that the new law does not legalize cannabis for anything other than medical use.
“It seeks to establish a clear national licensing scheme, where there will be a closed loop from seed to sale for the cultivation, processing, manufacturing and export of products derived from cannabis,” she said in the Senate.
New regulatory body
The law mandates the creation of the Barbados Medicinal Cannabis Licensing Authority, which will develop regulations to govern the industry.
The agency will be responsible for:
- Regulating medical cannabis.
- Issuing licenses.
- Establishing a database for the electronic tracking of cannabis.
- Establishing a register of practitioners, patients and caregivers.
After the agency is formed, it will be required to develop standards and codes of practice to be observed by licensees, as well as determining fees.
Business licenses will be available for:
- The cultivation of cannabis for medical purposes.
- Manufacturing of medical cannabis products.
- Dispensing at a therapeutic facility.
- Sale of medicinal cannabis.
- Research and development for medical or scientific purposes.
- Laboratory testing.
- Importing of medical cannabis.
- Exporting of medical cannabis.
Licenses will be valid for three years and are not renewable.
The Medicinal Cannabis Licensing Board will be formed to oversee the Medicinal Cannabis Licensing Authority.
Regulations might still be made with respect to:
- The administration and use of medical cannabis.
- Preventing “improper use” of medical cannabis.
- How medical marijuana is issued by pharmacists to patients.
- A minimum size of packages in which cannabis may be supplied.
Tier 1 cultivation licenses are limited to less than 1 acre. Second-tier permits will be limited to 1-5 acres and Tier 3 license holders will be allowed to cultivate more than 5 acres of medical cannabis.
Medical cannabis may be dispensed in a pharmacy or at a therapeutic facility.
A therapeutic facility is a premises that has been granted a Retail Distributor License to sell, dispense or provide medical cannabis prescribed or recommended by a medical practitioner.
Dispensing may be conducted only by a pharmacist or authorized personnel under the supervision of a pharmacist.
Where a prescription or recommendation by a medical practitioner requires repeated usage of medical marijuana, a pharmacy or therapeutic facility will not be allowed to supply more than 30 days worth of medicine.
The Medicinal Cannabis Industry Bill, 2019, is available here.
The Sacramental Cannabis Bill, 2019, is available here.
Matt Lamers is Marijuana Business Daily’s international editor, based near Toronto. He can be reached at firstname.lastname@example.org.